Skip to main content

Want a detailed portfolio tracker?

Elicio Therapeutics (ELTX) P/E (2021 - 2026)

Elicio Therapeutics (ELTX) P/E from Feb 5, 2021 to Jul 20, 2026. The TTM Elicio Therapeutics (ELTX) P/E is -1.32. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Elicio Therapeutics (ELTX)

YearP/EChange
2026-1.32-60.68%
2025-3.36+221.41%
2024-1.05-11.63%
2023-1.18-67.84%
2022-3.68+133.05%
2021-1.58N/A

Comparison Elicio Therapeutics (ELTX) P/E with competitors

Elicio Therapeutics (ELTX) P/E is -1.32.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.13%
NBYStablecoin Development Corp0.00-100.33%
ENLVEnlivex Ltd0.07-105.66%
FGENFibroGen Inc0.24-118.17%
CHRSCoherus Biosciences Inc0.85-164.23%
FBIOFortress Biotech Inc0.95-171.84%
ORMPOramed Pharmaceuticals Inc1.50-213.77%
AGENAgenus Inc3.01-327.81%
INVAInnoviva Inc3.15-338.74%
VXRTVaxart Inc3.55-368.70%
CRMDCorMedix Inc3.63-374.65%
CVACCureVac N.V.4.45-436.51%
GLPGGalapagos NV4.86-467.79%
SRPTSarepta Therapeutics Inc4.88-469.55%
ABEOAbeona Therapeutics Inc5.39-507.81%
ABUSArbutus Biopharma Corp5.60-523.56%
ZVRAZevra Therapeutics Inc5.89-545.63%
SPROSpero Therapeutics Inc6.23-571.46%
CGENCompugen Ltd6.31-577.93%
RIGLRigel Pharmaceuticals6.87-620.18%
SLXNSilexion Therapeutics Corp7.30-652.27%
OMEROmeros Corporation9.26-800.84%
AUPHAurinia Pharmaceuticals Inc9.58-825.53%
PLXProtalix BioTherapeutics Inc10.89-924.39%
ACADAcadia Pharmaceuticals Inc11.73-987.79%
TBPHTheravance Biopharma Inc12.26-1028.18%
ADMAAdma Biologics Inc12.42-1039.99%
HRMYHarmony Biosciences Holdings Inc13.82-1146.12%
SABSSAB Biotherapeutics Inc14.14-1170.04%
NAGENiagen Bioscience Inc14.82-1221.66%
INCYIncyte Corp15.82-1297.69%
REGNRegeneron Pharmaceuticals Inc15.86-1300.27%
PBYIPuma Biotechnology Inc17.32-1410.71%
CPRXCatalyst Pharmaceuticals Inc17.44-1420.07%
EXELExelixis Inc17.54-1427.54%
TGTXTG Therapeutics Inc18.97-1535.64%
MDXGMimedx Group Inc20.55-1655.72%
XOMAXOMA Royalty Corp22.87-1831.55%
ARGXArgen X SE24.30-1939.29%
CTMXCytomX Therapeutics Inc24.82-1978.88%
XOMAOXOMA Royalty Corp25.34-2018.53%
HALOHalozyme Therapeutics Inc25.62-2039.64%
XOMAPXOMA Royalty Corp25.67-2043.15%
VRTXVertex Pharmaceuticals Inc27.99-2219.12%
RPRXRoyalty Pharma plc - Class A28.69-2271.56%
SLNOSoleno Therapeutics Inc29.02-2296.37%
ASNDAscendis Pharma A/S30.09-2377.39%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2969.83%
APLSApellis Pharmaceuticals Inc39.02-3053.79%
BMRNBiomarin Pharmaceutical Inc42.21-3295.31%
KRYSKrystal Biotech Inc45.34-3532.37%
ONCBeiGene Ltd69.54-5364.01%
PHARPharming Group N.V.75.03-5779.22%
TECHBio-Techne Corp101.96-7817.95%
VCELVericel Corp109.92-8420.72%
ALNYAlnylam Pharmaceuticals Inc117.96-9029.61%
GMABGenmab140.29-10719.60%
TLXTelix Pharmaceuticals Ltd162.15-12374.49%
CORTCorcept Therapeutics Inc212.86-16212.69%